Neurocarrus
neurocarrus.com
Health Care
Neurology & CNS Therapeutics
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Grants
$3M
2 grants · CORDIS
Backers
1
SOSV
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | Neurocarrus Inc | SEC Form D |
Backed byfrom the funds' portfolios and accelerator catalogs
SOSV Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Accelerating the development of better drugs for better targets in a quest to alter the trajectory of neurodegenerative disease.
Midstage biotech developing GRX-917, a non-addictive anxiety treatment with minimal side effects. Pivotal trials 2027, projected FDA…
At Sentinal4D, we believe patients battling cancer, neurodegenerative diseases, and chronic inflammatory syndromes deserve personalized…
Advancing medicines to restore homeostasis. Cajal Therapeutics is developing novel medicines for serious diseases, including anemias of…
Overview
What is Neurocarrus?Treating Neurodegenerative Disease and Pain Without Addiction.Neurocarrus is a biotech company developing a novel drug technology to safely target neurodegeneration and pain without risk of addiction or other systemic effects.Learn More Our crowd funding raise has started.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Monterey
United States
HQ
10-50 est. staff